RAD54L2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.509440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.033400E-01
Normal-vs-Stage2
1.720980E-01
Normal-vs-Stage3
1.843160E-01
Normal-vs-Stage4
9.218000E-01
Stage1-vs-Stage2
6.701600E-01
Stage1-vs-Stage3
2.964000E-02
Stage1-vs-Stage4
4.191600E-01
Stage2-vs-Stage3
3.984900E-04
Stage2-vs-Stage4
1.697990E-01
Stage3-vs-Stage4
8.513600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.230790E-01
Normal-vs-AfricanAmerican
9.763400E-01
Normal-vs-Asian
6.679800E-02
Caucasian-vs-AfricanAmerican
2.480200E-01
Caucasian-vs-Asian
2.180400E-01
AfricanAmerican-vs-Asian
1.321780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.289760E-01
Normal-vs-Female
2.054400E-01
Male-vs-Female
5.025200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.231400E-01
Normal-vs-Age(41-60Yrs)
3.765000E-01
Normal-vs-Age(61-80Yrs)
1.020170E-01
Normal-vs-Age(81-100Yrs)
3.602000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.991000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.375000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.683400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.166410E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.640100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.546760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.837500E-02
Normal-vs-Daily Drinker
3.020300E-02
Normal-vs-Weekly Drinker
1.374810E-01
Normal-vs-Occasional Drinker
1.701630E-01
Normal-vs-Social Drinker
4.465000E-01
Non Drinker-vs-Daily Drinker
5.175000E-01
Non Drinker-vs-Weekly Drinker
8.033400E-01
Non Drinker-vs-Occasional Drinker
4.333800E-01
Non Drinker-vs-Social Drinker
1.426020E-01
Daily Drinker-vs-Weekly Drinker
4.571800E-01
Daily Drinker-vs-Occasional Drinker
2.023600E-01
Daily Drinker-vs-Social Drinker
7.436500E-02
Weekly Drinker-vs-Occasional Drinker
6.886400E-01
Weekly Drinker-vs-Social Drinker
3.441000E-01
Occasional Drinker-vs-Social Drinker
4.945600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.034400E-01
Normal-vs-Grade 2
1.028370E-01
Normal-vs-Grade 3
6.284400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.959200E-01
Grade 1-vs-Grade 3
9.332800E-01
Grade 1-vs-Grade 4
2.034400E-01
Grade 2-vs-Grade 3
6.012400E-01
Grade 2-vs-Grade 4
1.028370E-01
Grade 3-vs-Grade 4
6.284400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.700300E-02
Normal-vs-NonDiabetic
6.742200E-02
Diabetic-vs-NonDiabetic
9.826000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.891800E-01
Normal-vs-NoPancreatitis
9.892200E-02
Pancreatitis-vs-NoPancreatitis
2.736000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.729620E-01
Normal-vs-N1
1.652790E-01
N0-vs-N1
6.373200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.623610E-01
Normal-vs-TP53-NonMutant
3.994000E-01
TP53-Mutant-vs-TP53-NonMutant
1.745030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
